518 related articles for article (PubMed ID: 34411992)
21. Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study.
Ladoire S; Rederstorff E; Goussot V; Parnalland S; Briot N; Ballot E; Truntzer C; Ayati S; Bengrine-Lefevre L; Bremaud N; Coudert B; Desmoulins I; Favier L; Fraisse C; Fumet JD; Hennequin A; Hervieu A; Ilie S; Kaderbhai C; Lagrange A; Martin N; Mazilu I; Mayeur D; Palmier R; Simonet-Lamm AL; Vincent J; Zanetta S; Arnould L; Coutant C; Bertaut A; Ghiringhelli F
Eur J Cancer; 2022 Apr; 165():13-24. PubMed ID: 35189537
[TBL] [Abstract][Full Text] [Related]
22. Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June-July 2021: A population-based cross-sectional study.
Murhekar MV; Bhatnagar T; Thangaraj JWV; Saravanakumar V; Santhosh Kumar M; Selvaraju S; Rade K; Kumar CPG; Sabarinathan R; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chakraborty D; Chopra V; Das D; Devi KR; Dwivedi GR; Jain A; Khan SMS; Kumar MS; Laxmaiah A; Madhukar M; Mahapatra A; Ramesh T; Rangaraju C; Turuk J; Yadav S; Bhargava B;
PLoS Med; 2021 Dec; 18(12):e1003877. PubMed ID: 34890407
[TBL] [Abstract][Full Text] [Related]
23. The Seroprevalence of SARS-CoV-2 in Children During Early COVID-19 Pandemic in Korea: A Nationwide, Population-Based Study.
Lee J; Choe YJ; Minn D; Kim JH
J Korean Med Sci; 2022 Nov; 37(44):e314. PubMed ID: 36377292
[TBL] [Abstract][Full Text] [Related]
24. Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.
Jones JM; Stone M; Sulaeman H; Fink RV; Dave H; Levy ME; Di Germanio C; Green V; Notari E; Saa P; Biggerstaff BJ; Strauss D; Kessler D; Vassallo R; Reik R; Rossmann S; Destree M; Nguyen KA; Sayers M; Lough C; Bougie DW; Ritter M; Latoni G; Weales B; Sime S; Gorlin J; Brown NE; Gould CV; Berney K; Benoit TJ; Miller MJ; Freeman D; Kartik D; Fry AM; Azziz-Baumgartner E; Hall AJ; MacNeil A; Gundlapalli AV; Basavaraju SV; Gerber SI; Patton ME; Custer B; Williamson P; Simmons G; Thornburg NJ; Kleinman S; Stramer SL; Opsomer J; Busch MP
JAMA; 2021 Oct; 326(14):1400-1409. PubMed ID: 34473201
[TBL] [Abstract][Full Text] [Related]
25. Utility of Newborn Dried Blood Spots to Ascertain Seroprevalence of SARS-CoV-2 Antibodies Among Individuals Giving Birth in New York State, November 2019 to November 2021.
Damjanovic A; Styer LM; Nemeth K; Yauney E; Rock JM; Bievenue R; Hoen R; Ehrbar D; Kay DM; Caggana M; Parker MM
JAMA Netw Open; 2022 Aug; 5(8):e2227995. PubMed ID: 35994287
[TBL] [Abstract][Full Text] [Related]
26. SARS-CoV-2 exposure in Malawian blood donors: an analysis of seroprevalence and variant dynamics between January 2020 and July 2021.
Mandolo J; Msefula J; Henrion MYR; Brown C; Moyo B; Samon A; Moyo-Gwete T; Makhado Z; Ayres F; Motlou T; Mzindle N; Kalata N; Muula AS; Kwatra G; Nsamala N; Likaka A; Mfune T; Moore PL; Mbaya B; French N; Heyderman RS; Swarthout T; Jambo KC
BMC Med; 2021 Nov; 19(1):303. PubMed ID: 34794434
[TBL] [Abstract][Full Text] [Related]
27. Estimate of anti-SARS-CoV-2 spike IgG antibodies prevalence among Iranian population based on blood donations: A serial cross-sectional study during the third wave of the pandemic.
Ranjbar Kermani F; Arabkhazaeli A; Eshghi P; Maghsudlu M; Amini-Kafiabad S; Teimourpour A; Pourkarim MR
Transfus Clin Biol; 2023 Feb; 30(1):123-129. PubMed ID: 36084918
[TBL] [Abstract][Full Text] [Related]
28. Seroprevalence of SARS-CoV-2 antibodies among blood donors in Québec: an update from a serial cross-sectional study.
Lewin A; De Serres G; Grégoire Y; Perreault J; Drouin M; Fournier MJ; Tremblay T; Beaudoin J; Boivin A; Goyette G; Finzi A; Bazin R; Germain M; Delage G; Renaud C
Can J Public Health; 2022 Jun; 113(3):385-393. PubMed ID: 35380364
[TBL] [Abstract][Full Text] [Related]
29. Dynamics of SARS-CoV-2 seroprevalence during the first year of the COVID-19 pandemic in the Northeast region of Brazil.
de Souza Araújo AA; Quintans-Júnior LJ; Heimfarth L; Schimieguel DM; Corrêa CB; de Moura TR; Cavalcante RCM; Grespan R; de Souza Siqueira Quintans J; Dos Santos DM; da Silva DN; de Oliveira YLM; de Franca MNF; da Conceição Silva M; de Sá DLF; de Carvalho FO; de Souza MF; de Oliveira Góes MA; Santos VS; Martins-Filho PR
Pathog Glob Health; 2023 Jul; 117(5):505-512. PubMed ID: 36094065
[TBL] [Abstract][Full Text] [Related]
30. Seroprevalence of SARS-CoV-2 antibodies among first-trimester pregnant women during the second wave of the pandemic in India.
Sharma KA; Singh N; Hillman S; Mathur P; Yadav K; Garg A; Dadhwal V; Bhatla N
Int J Gynaecol Obstet; 2023 Jan; 160(1):74-78. PubMed ID: 35324007
[TBL] [Abstract][Full Text] [Related]
31. Seroprevalence of SARS-CoV-2 infection and associated factors among Bangladeshi slum and non-slum dwellers in pre-COVID-19 vaccination era: October 2020 to February 2021.
Raqib R; Sarker P; Akhtar E; Nurul Huda TM; Haq MA; Roy AK; Hosen MB; Haque F; Chowdhury MR; Reidpath DD; Emdadul Hoque DM; Islam Z; Ahmed S; Ahmed T; Tofail F; Razzaque A
PLoS One; 2022; 17(5):e0268093. PubMed ID: 35604947
[TBL] [Abstract][Full Text] [Related]
32. Main differences between the first and second waves of COVID-19 in Madrid, Spain.
Soriano V; Ganado-Pinilla P; Sanchez-Santos M; Gómez-Gallego F; Barreiro P; de Mendoza C; Corral O
Int J Infect Dis; 2021 Apr; 105():374-376. PubMed ID: 33684560
[TBL] [Abstract][Full Text] [Related]
33. Seroprevalence of SARS-CoV-2 Infection in Portugal in May-July 2020: Results of the First National Serological Survey (ISNCOVID-19).
Kislaya I; Gonçalves P; Barreto M; Sousa R; Garcia AC; Matos R; Guiomar R; Rodrigues AP;
Acta Med Port; 2021 Feb; 34(2):87-94. PubMed ID: 33641702
[TBL] [Abstract][Full Text] [Related]
34. Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study.
Zamani M; Poustchi H; Mohammadi Z; Dalvand S; Sharafkhah M; Motevalian SA; Eslami S; Emami A; Somi MH; Yazdani-Charati J; Saki N; Karami M; Najafi F; Mohebbi I; Veisi N; Hormati A; Pourfarzi F; Ghadimi R; Ansari-Moghaddam A; Sharifi H; Roshandel G; Mansour-Ghanaei F; Joukar F; Shayanrad A; Eghtesad S; Niavarani A; Delavari A; Kaveh S; Feizesani A; Markarian M; Shafighian F; Sadjadi A; Darvishian M; Malekzadeh R
BMC Public Health; 2022 May; 22(1):1031. PubMed ID: 35606743
[TBL] [Abstract][Full Text] [Related]
35. Trends in seroprevalence of SARS-CoV-2 and infection fatality rate in the Norwegian population through the first year of the COVID-19 pandemic.
Tunheim G; Rø GØI; Tran T; Kran AB; Andersen JT; Vaage EB; Kolderup A; Vaage JT; Lund-Johansen F; Hungnes O
Influenza Other Respir Viruses; 2022 Mar; 16(2):204-212. PubMed ID: 34751488
[TBL] [Abstract][Full Text] [Related]
36. SARS-CoV-2 seroprevalence in pregnant women during the first three COVID-19 waves in The Gambia.
Janha RE; Bah A; Jah H; Touray F; Idris Y; Keita S; Gaye Y; Jallow S; Faye-Joof T; Njie B; Craik R; Mohammed NI; von Dadelszen P; D'Alessandro U; Roca A;
Int J Infect Dis; 2023 Oct; 135():109-117. PubMed ID: 37586660
[TBL] [Abstract][Full Text] [Related]
37. Seroprevalence kinetics of SARS-CoV-2 antibodies in pediatric patients visiting a hospital during COVID-19 pandemic in Japan.
Hashimoto T; Yahiro T; Khan S; Kimitsuki K; Suzuki M; Fujimoto T; Tanaka T; Saito N; Hiramatsu K; Nishizono A
J Infect Chemother; 2024 Feb; 30(2):169-171. PubMed ID: 37734592
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies in the Mozambican Population: A Cross-Sectional Serologic Study in 3 Cities, July-August 2020.
Arnaldo P; Mabunda N; Young PW; Tran T; Sitoe N; Chelene I; Nhanombe A; Ismael N; Júnior A; Cubula B; Inlamea OF; Gudo E; Jani IV
Clin Infect Dis; 2022 Oct; 75(Suppl 2):S285-S293. PubMed ID: 35748663
[TBL] [Abstract][Full Text] [Related]
39. High prevalence of SARS-CoV-2 antibodies in pregnant women after the second wave of infections in the inner-city of Johannesburg, Gauteng Province, South Africa.
Sawry S; Le Roux J; Wolter N; Mbatha P; Bhiman J; Balkus J; von Gottberg A; Cohen C; Chersich M; Kekana M; Ndlovu T; Shipalana A; Mthimunye W; Patel F; Gous H; Walaza S; Tempia S; Rees H; Fairlie L
Int J Infect Dis; 2022 Dec; 125():241-249. PubMed ID: 36347458
[TBL] [Abstract][Full Text] [Related]
40. Seroprevalence of SARS-CoV-2 Antibodies Among Children in School and Day Care in Montreal, Canada.
Zinszer K; McKinnon B; Bourque N; Pierce L; Saucier A; Otis A; Cheriet I; Papenburg J; Hamelin MÈ; Charland K; Carbonneau J; Zahreddine M; Savard A; Fortin G; Apostolatos A; Haley N; Ratté N; Laurin I; Nguyen CT; Conrod P; Boivin G; De Serres G; Quach C
JAMA Netw Open; 2021 Nov; 4(11):e2135975. PubMed ID: 34812845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
